Drug-induced liver injury associated with elexacaftor/tezacaftor/ivacaftor: A pharmacovigilance analysis of the FDA adverse event reporting system (FAERS)
Alan Shi, H. Nguyen, Chiaoyun Benson Kuo, Paul M. Beringer
Topics & Concepts
Adverse Event Reporting SystemMedicineIvacaftorPharmacovigilanceAdverse effectOdds ratioInternal medicineCystic fibrosis transmembrane conductance regulatorCystic fibrosisDrug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug ReactionsCystic Fibrosis Research Advances